Cargando…

Evolution of Medical Approaches and Prominent Therapies in Breast Cancer

SIMPLE SUMMARY: Breast cancer is a leading cause of morbidity and mortality in women worldwide, with mortality rates largely driven by metastatic disease. Despite concerted efforts to uncover and target the mechanisms underlying these events, the five-year relative survival rate for metastatic breas...

Descripción completa

Detalles Bibliográficos
Autores principales: Duan, Suzann, Buxton, Iain L. O.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9140094/
https://www.ncbi.nlm.nih.gov/pubmed/35626053
http://dx.doi.org/10.3390/cancers14102450
_version_ 1784715014747193344
author Duan, Suzann
Buxton, Iain L. O.
author_facet Duan, Suzann
Buxton, Iain L. O.
author_sort Duan, Suzann
collection PubMed
description SIMPLE SUMMARY: Breast cancer is a leading cause of morbidity and mortality in women worldwide, with mortality rates largely driven by metastatic disease. Despite concerted efforts to uncover and target the mechanisms underlying these events, the five-year relative survival rate for metastatic breast cancer remains an abysmal 27%. To better inform future directions for managing this disease, it is helpful to examine the evolution of cancer research, from foundational concepts to therapies and their pitfalls. This review aims to provide a rich overview of the history of breast cancer therapies spanning antiquity to the modern era, concluding with the rapid advancements in immunotherapies and our eventual progression towards personalized medicine. ABSTRACT: An examination of the origins of medical approaches to breast cancer marks this disease as one of the most difficult to manage. As the early identification, diagnosis and treatment of breast cancer evolve, we will move to a time when each patient and their cancer can be assessed to determine unique patient-specific (personalized) approaches to therapy. Humans have attempted to manage breast cancer for millennia. Even today, the disease claims thousands of lives each year. In light of the increasingly sophisticated understanding of cancer diagnosis and treatment, together with our ultimate failure to offer a cure in the most difficult cases, it is instructive to reflect on the beginnings of our understanding.
format Online
Article
Text
id pubmed-9140094
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-91400942022-05-28 Evolution of Medical Approaches and Prominent Therapies in Breast Cancer Duan, Suzann Buxton, Iain L. O. Cancers (Basel) Review SIMPLE SUMMARY: Breast cancer is a leading cause of morbidity and mortality in women worldwide, with mortality rates largely driven by metastatic disease. Despite concerted efforts to uncover and target the mechanisms underlying these events, the five-year relative survival rate for metastatic breast cancer remains an abysmal 27%. To better inform future directions for managing this disease, it is helpful to examine the evolution of cancer research, from foundational concepts to therapies and their pitfalls. This review aims to provide a rich overview of the history of breast cancer therapies spanning antiquity to the modern era, concluding with the rapid advancements in immunotherapies and our eventual progression towards personalized medicine. ABSTRACT: An examination of the origins of medical approaches to breast cancer marks this disease as one of the most difficult to manage. As the early identification, diagnosis and treatment of breast cancer evolve, we will move to a time when each patient and their cancer can be assessed to determine unique patient-specific (personalized) approaches to therapy. Humans have attempted to manage breast cancer for millennia. Even today, the disease claims thousands of lives each year. In light of the increasingly sophisticated understanding of cancer diagnosis and treatment, together with our ultimate failure to offer a cure in the most difficult cases, it is instructive to reflect on the beginnings of our understanding. MDPI 2022-05-16 /pmc/articles/PMC9140094/ /pubmed/35626053 http://dx.doi.org/10.3390/cancers14102450 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Review
Duan, Suzann
Buxton, Iain L. O.
Evolution of Medical Approaches and Prominent Therapies in Breast Cancer
title Evolution of Medical Approaches and Prominent Therapies in Breast Cancer
title_full Evolution of Medical Approaches and Prominent Therapies in Breast Cancer
title_fullStr Evolution of Medical Approaches and Prominent Therapies in Breast Cancer
title_full_unstemmed Evolution of Medical Approaches and Prominent Therapies in Breast Cancer
title_short Evolution of Medical Approaches and Prominent Therapies in Breast Cancer
title_sort evolution of medical approaches and prominent therapies in breast cancer
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9140094/
https://www.ncbi.nlm.nih.gov/pubmed/35626053
http://dx.doi.org/10.3390/cancers14102450
work_keys_str_mv AT duansuzann evolutionofmedicalapproachesandprominenttherapiesinbreastcancer
AT buxtoniainlo evolutionofmedicalapproachesandprominenttherapiesinbreastcancer